Psoriatic Arthritis News and Research

RSS
Like rheumatoid arthritis (RA), psoriatic arthritis is a chronic inflammatory disease of the joints and connective tissue. The disease causes joint pain and swelling that can lead to crippling along with inflamed and irritated scaly red patches of skin throughout the body. It is a progressive and debilitating disease and because there are no treatments specifically approved for psoriatic arthritis, doctors often use therapies approved for RA, including nonsteroidal anti-inflammatory drugs (NSAIDs) and disease modifying anti-rheumatic drugs (DMARDs). However, no DMARDs are currently approved for use in psoriatic arthritis. There are approximately 300,000 patients with psoriatic arthritis in the United States and the disease affects both men and women most commonly between the ages 30 and 50. Psoriatic arthritis patients are generally treated by rheumatologists and dermatologists.
Combining medications often best strategy to battle rheumatoid arthritis

Combining medications often best strategy to battle rheumatoid arthritis

Smoking linked to enduring risk of psoriasis

Smoking linked to enduring risk of psoriasis

Researchers shed light on the link between chronic inflammation and atherosclerosis

Researchers shed light on the link between chronic inflammation and atherosclerosis

Abbott seeks U.S. and E.U. approvals for Humira as a treatment for juvenile rheumatoid arthritis

Abbott seeks U.S. and E.U. approvals for Humira as a treatment for juvenile rheumatoid arthritis

Abbott opens biotech facility in Puerto Rico

Abbott opens biotech facility in Puerto Rico

New Crohn's disease treatment Humira promises to reduce symptoms

New Crohn's disease treatment Humira promises to reduce symptoms

FDA approves Humira (adalimumab) for Crohn's disease

FDA approves Humira (adalimumab) for Crohn's disease

Remicade receives European approval for treatment of psoriatic arthritis

Remicade receives European approval for treatment of psoriatic arthritis

NICE backs use of Enbrel and Raptiva to treat severe psoriasis

NICE backs use of Enbrel and Raptiva to treat severe psoriasis

Arthritis drug wins approval for use in children with Crohn's disease

Arthritis drug wins approval for use in children with Crohn's disease

Remicade (infliximab) gains Australian approval for treatment of early rheumatoid arthritis

Remicade (infliximab) gains Australian approval for treatment of early rheumatoid arthritis

Discovery of common genetic variation in an immune system gene that makes people much more likely to develop psoriasis

Discovery of common genetic variation in an immune system gene that makes people much more likely to develop psoriasis

Specific guidelines for treating juvenile idiopathic arthritis

Specific guidelines for treating juvenile idiopathic arthritis

First true animal model for psoriasis

First true animal model for psoriasis

Abbott receives European approval to market Humira

Abbott receives European approval to market Humira

Biologic treatments to treat the physical symptoms of psoriasis

Biologic treatments to treat the physical symptoms of psoriasis

Arthritis patients still suffer as drugs guidelines are ignored

Arthritis patients still suffer as drugs guidelines are ignored

Experts call for improved access to treatment for psoriatic arthritis

Experts call for improved access to treatment for psoriatic arthritis

Biologic therapies are changing the way dermatologists treat psoriasis

Biologic therapies are changing the way dermatologists treat psoriasis

Trial of Etanercept for Wegners's disease shows no benefit against the autoimmune condition

Trial of Etanercept for Wegners's disease shows no benefit against the autoimmune condition